In July 2018 I wrote about the part that point of care ultrasound (POCUS) would play in the future of the imaging market. I’m not sure where two years have gone, but since then the companies, personnel and their technology have evolved considerably.
Fresh approaches to AI, mixed reality, surgical robotics and CCM are changing the way we think about cardiology.
.jpg)
The demand for wound care is at an all-time high, sparking innovation from all corners of the industry.
Global ambitions, a large market-size and truly disruptive technology, are all great indicators of a company that's about to make it big in medical imaging. But which companies have these top traits?
There’s no perfect formula to becoming a successful billion-dollar company in medical imaging, or else we’d all be billionaires. However, this combination of ingredients does seem to create a common recipe for success.
Now more than ever, medical imaging is dependent on an underlying digital infrastructure. While there's a clear medical benefit, cyber security is an rising concern throughout the industry.
I’m championing three emerging companies whose technology has led their ambition, rather than R&D budgets, mergers and acquisitions.
Artificial Intelligence is a new technology and, for the most part, one of its biggest challenges is just working out how it will be applied. Where it can be used best, most cost-effectively and easiest to gain the best results.
It’s difficult to measure the impact of any technology on the orthopaedics sector. That’s because the term covers such a wide range of different procedures, products and areas of the human body.
Writing for Nursing Times.net, Jacqui Fletcher referred to wound care as a ‘significant burden’ for the UK’s NHS, with the cost of treating wounds calculated at well over £5 billion per year, and rising.
